… Therefore, other biomarkers have … checkpoint inhibitor (ICI) therapy in general. Of those,
TMB has been extensively studied as an alternative or complementary biomarker for response to …

… predictors of ICI response (13, 14). Here we explored proposed biomarkers of ICI sensitivity
in a … the primary focus of this study for examining genomic biomarkers predictive of response. …

… profiling, and liquid biomarkers such as systemic inflammatory … outcome and its use as a
biomarker of response and toxicity. … and future biomarkers of response, resistance and toxicity. …

… other potential biomarkers of immunotherapy response, we … PD-L1, positivity, and
immunotherapy response. This finding … exhibit similar response rates to checkpoint inhibitor …

… response to PD-1 inhibitors, which limited the clinical applications of anti-PD-1/PD-L1 therapy
5 . Predictive biomarkers … This article reviewed current potential biomarkers by categories …

… with outcomes of immune checkpoint inhibition. Here, we review the reported predictive
biomarkers of response to PD-1 pathway immune checkpoint inhibitors in NSCLC, mainly …

… likelihood of response. There is a wide range of methodologies investigating predictive
biomarkers in this space; in this review, we address the major putative biomarkers of interest. …

… emerging data on new biomarker strategies with tumour-… effective predictive biomarker
for checkpoint inhibitor-based … of biomarkers as aids to checkpoint inhibitor immunotherapy …

… appropriate predictive biomarkers of response to optimize patient selection for immune
checkpoint inhibitor (ICI) therapy remains a challenge. The programmed death 1 (PD-1) inhibitor …

… circulating T-cell biomarker, we analyze … response to anti-PD-1 therapy. Our results support
circulating CX3CR1 + CD8 + T cells as an early on-treatment biomarker of clinical response …